Article
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2015
Komatsu Masaaki, Wheeler Heather E, Chung Suyoun, Low Siew-Kee, Wing Claudia, Delaney Shannon M, Gorsic Lidija K, Takahashi Atsushi, Kubo Michiaki, Kroetz Deanna L, Zhang Wei, Nakamura Yusuke, Dolan M Eileen
Abstract excerpt
PURPOSE: Paclitaxel is used worldwide in the treatment of breast, lung, ovarian, and other cancers. Sensory peripheral neuropathy is an associated adverse effect that cannot be predicted, prevented, or mitigated. To better understand the contribution of germline genetic variation to paclitaxel-induced peripheral neuropathy, we undertook an integrative approach that combines genome-wide association study (GWAS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
